- Home
- / Dong-A ST
Dong-A ST
Stock Price
₩75.3 K
2024-10-29
Market Capitalization
₩666.3 B
2024-10-29
Revenue
₩808.8 B
FY, 2025
Dong-A ST Summary
Company Summary
- Overview
- Dong-A ST is a healthcare company that specializes in the development of ethical drugs and medical devices. It provides a range of prescribed medications, including Stillen, Zydena, Motilitone, etc.
- Type
- Public
- Status
- Active
- Founded
- 1932
- Website
- http://en.donga-st.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Dong-A ST Financials
Summary Financials
- Revenue (Q1, 2026)
- ₩203.6B
- Gross profit (Q1, 2026)
- ₩93.5B
- Net income (Q1, 2026)
- ₩7.9B
- Cash (Q1, 2026)
- ₩228.6B
- EBIT (Q1, 2026)
- ₩4.4B
- Enterprise value
- $1.0T
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026